Here is how American Healthcare REIT (AHR) and BlackRock (BLK) have performed compared to their sector so far this year.
American Healthcare REIT, Inc. (AHR) Q2 2026 Earnings Call Transcript
American Healthcare REIT NYSE: AHR reported second-quarter normalized funds from operations of $0.54 per diluted share, a 28.6% increase from $0.42 a year earlier, as same-store net operating income growth, acquisition contributions and expense controls supported results.
American Healthcare REIT is well-positioned for growth, benefiting from robust sector fundamentals and demographic tailwinds in senior housing. AHR demonstrates strong same-store NOI growth, disciplined balance sheet management, and an active acquisition pipeline focused on distressed SHOP assets. Despite impressive performance and macro tailwinds, I rate AHR a Hold due to strong competition, aging properties, and a relatively passive acquisition strategy.
Investors need to pay close attention to AHR stock based on the movements in the options market lately.
Here is how American Healthcare REIT (AHR) and First BanCorp (FBP) have performed compared to their sector so far this year.
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how American Healthcare REIT (AHR) and Skyward Specialty Insurance (SKWD) have performed compared to their sector so far this year.
Here is how American Healthcare REIT (AHR) and Alerus (ALRS) have performed compared to their sector so far this year.
Smart money is piling into data centers and senior housing. One top activist REIT investor is making contrarian bets. INVH and NHI could be overlooked beneficiaries.
AI-driven capex and senior housing demand are the dominant growth trends shaping my current buy list. Despite a resurgence in inflation and soaring interest rates, stocks remain resilient, fueled by robust AI infrastructure spending. I am allocating fresh capital to three stocks and three ETFs, targeting dividend growth and AI exposure.
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).